BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 23402884)

  • 1. HDAC6 promotes hepatocellular carcinoma progression by inhibiting P53 transcriptional activity.
    Ding G; Liu HD; Huang Q; Liang HX; Ding ZH; Liao ZJ; Huang G
    FEBS Lett; 2013 Apr; 587(7):880-6. PubMed ID: 23402884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C/EBPalpha is up-regulated in a subset of hepatocellular carcinomas and plays a role in cell growth and proliferation.
    Lu GD; Leung CH; Yan B; Tan CM; Low SY; Aung MO; Salto-Tellez M; Lim SG; Hooi SC
    Gastroenterology; 2010 Aug; 139(2):632-43, 643.e1-4. PubMed ID: 20347819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Downregulation of HDAC6 promotes angiogenesis in hepatocellular carcinoma cells and predicts poor prognosis in liver transplantation patients.
    Lv Z; Weng X; Du C; Zhang C; Xiao H; Cai X; Ye S; Cheng J; Ding C; Xie H; Zhou L; Wu J; Zheng S
    Mol Carcinog; 2016 May; 55(5):1024-33. PubMed ID: 26086159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histone deacetylase 6 functions as a tumor suppressor by activating c-Jun NH2-terminal kinase-mediated beclin 1-dependent autophagic cell death in liver cancer.
    Jung KH; Noh JH; Kim JK; Eun JW; Bae HJ; Chang YG; Kim MG; Park WS; Lee JY; Lee SY; Chu IS; Nam SW
    Hepatology; 2012 Aug; 56(2):644-57. PubMed ID: 22392728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The E2F transcription factor 1 transactives stathmin 1 in hepatocellular carcinoma.
    Chen YL; Uen YH; Li CF; Horng KC; Chen LR; Wu WR; Tseng HY; Huang HY; Wu LC; Shiue YL
    Ann Surg Oncol; 2013 Nov; 20(12):4041-54. PubMed ID: 22911364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of histone deacetylase 6 contributes to accelerated migration and invasion activity of hepatocellular carcinoma cells.
    Kanno K; Kanno S; Nitta H; Uesugi N; Sugai T; Masuda T; Wakabayashi G; Maesawa C
    Oncol Rep; 2012 Sep; 28(3):867-73. PubMed ID: 22766642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcription factor KLF9 suppresses the growth of hepatocellular carcinoma cells in vivo and positively regulates p53 expression.
    Sun J; Wang B; Liu Y; Zhang L; Ma A; Yang Z; Ji Y; Liu Y
    Cancer Lett; 2014 Dec; 355(1):25-33. PubMed ID: 25242357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A possible connection between adhesion regulating molecule 1 overexpression and nuclear factor kappa B activity in hepatocarcinogenesis.
    Yang X; Miao X; Wen Y; Hu J; Dai W; Yin B
    Oncol Rep; 2012 Jul; 28(1):283-90. PubMed ID: 22576803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcription Factor MafB Promotes Hepatocellular Carcinoma Cell Proliferation through Up-Regulation of Cyclin D1.
    Yu H; Jiang HL; Xu D; Jin JZ; Zhao ZM; Ma YD; Liang J
    Cell Physiol Biochem; 2016; 39(2):700-8. PubMed ID: 27448450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapamycin regulates the proliferation of Huh7, a hepatocellular carcinoma cell line, by up-regulating p53 expression.
    Kwon S; Jeon JS; Ahn C; Sung JS; Choi I
    Biochem Biophys Res Commun; 2016 Oct; 479(1):74-9. PubMed ID: 27616194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Menatetrenone, a vitamin K2 analogue, inhibits hepatocellular carcinoma cell growth by suppressing cyclin D1 expression through inhibition of nuclear factor kappaB activation.
    Ozaki I; Zhang H; Mizuta T; Ide Y; Eguchi Y; Yasutake T; Sakamaki T; Pestell RG; Yamamoto K
    Clin Cancer Res; 2007 Apr; 13(7):2236-45. PubMed ID: 17404108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acetaldehyde induces matrix metalloproteinase-9 gene expression via nuclear factor-kappaB and activator protein 1 signaling pathways in human hepatocellular carcinoma cells: Association with the invasive potential.
    Hsiang CY; Wu SL; Chen JC; Lo HY; Li CC; Chiang SY; Wu HC; Ho TY
    Toxicol Lett; 2007 Jun; 171(1-2):78-86. PubMed ID: 17543481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Down-regulation of CYLD as a trigger for NF-κB activation and a mechanism of apoptotic resistance in hepatocellular carcinoma cells.
    Urbanik T; Köhler BC; Boger RJ; Wörns MA; Heeger S; Otto G; Hövelmeyer N; Galle PR; Schuchmann M; Waisman A; Schulze-Bergkamen H
    Int J Oncol; 2011 Jan; 38(1):121-31. PubMed ID: 21109933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted disruption of S100P suppresses tumor cell growth by down-regulation of cyclin D1 and CDK2 in human hepatocellular carcinoma.
    Kim JK; Jung KH; Noh JH; Eun JW; Bae HJ; Xie HJ; Ahn YM; Ryu JC; Park WS; Lee JY; Nam SW
    Int J Oncol; 2009 Dec; 35(6):1257-64. PubMed ID: 19885547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NF-κB increased expression of 17β-hydroxysteroid dehydrogenase 4 promotes HepG2 proliferation via inactivating estradiol.
    Lu X; Ma P; Shi Y; Yao M; Hou L; Zhang P; Jiang L
    Mol Cell Endocrinol; 2015 Feb; 401():1-11. PubMed ID: 25448063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ING1 represses transcription by direct DNA binding and through effects on p53.
    Kataoka H; Bonnefin P; Vieyra D; Feng X; Hara Y; Miura Y; Joh T; Nakabayashi H; Vaziri H; Harris CC; Riabowol K
    Cancer Res; 2003 Sep; 63(18):5785-92. PubMed ID: 14522900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LIM and SH3 protein 1 (Lasp1) is a novel p53 transcriptional target involved in hepatocellular carcinoma.
    Wang B; Feng P; Xiao Z; Ren EC
    J Hepatol; 2009 Mar; 50(3):528-37. PubMed ID: 19155088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased expression of integrin beta1 subunit enhances p21WAF1/Cip1 transcription through the Sp1 sites and p300-mediated histone acetylation in human hepatocellular carcinoma cells.
    Fang Z; Fu Y; Liang Y; Li Z; Zhang W; Jin J; Yang Y; Zha X
    J Cell Biochem; 2007 Jun; 101(3):654-64. PubMed ID: 17211849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nuclear α1-antichymotrypsin promotes chromatin condensation and inhibits proliferation of human hepatocellular carcinoma cells.
    Santamaria M; Pardo-Saganta A; Alvarez-Asiain L; Di Scala M; Qian C; Prieto J; Avila MA
    Gastroenterology; 2013 Apr; 144(4):818-828.e4. PubMed ID: 23295442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced nucleic ZHX2 involves in oncogenic activation of glypican 3 in human hepatocellular carcinoma.
    Luan F; Liu P; Ma H; Yue X; Liu J; Gao L; Liang X; Ma C
    Int J Biochem Cell Biol; 2014 Oct; 55():129-35. PubMed ID: 25195714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.